Moderna reiterated its full-year 2025 product sales forecast of $1.5 billion to $2.5 billion, with most expected in the ...

The Trump administration is investing $500M in a project to develop "universal" vaccines that protect against multiple virus ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

The US Food and Drug Administration will require all new vaccines to undergo placebo-controlled trials before approval — a ...

The maternal mortality rate rose to 19 deaths per 100,000 live births, up from 18.6 the year before. The CDC counts women who ...

Health and Human Services Secretary Robert F. Kennedy Jr. intends to shift the way vaccines are tested, a move that the agency said will increase transparency but that medical experts fear could limit ...

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

Novavax, Inc. (Nasdaq: NVAX) today announced the appointment of Charles Newton to its board as an independent director. Mr. Newton brings extensive experience in public markets and healthcare ...

Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Usha Lee McFarling ...

Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...